老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

151.43
-4.4300-2.84%
盘后：151.700.2700+0.18%17:54 EDT
成交量：65.59万
成交额：9,934.35万
市值：90.62亿
市盈率：-22.40
高：158.45
开：156.73
低：148.40
收：155.86
数据加载中...
总览公司新闻资讯公告
2020/10/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多